Darlene Dobkowski

In this on-demand webinar series, CURE partnered with Susan G. Komen Foundation and Roswell Park Comprehensive Cancer Center to learn more about how patients with breast cancer can connect with each other.

An expert explained how sentinel lymph node biopsy has helped surgeons remove fewer lymph nodes, which can reduce lymphedema risk in patients with breast cancer.

INT230-6 combines cisplatin, vinblastine, and a penetration enhancer for intratumor injection, aiming to engage the immune system without immunosuppression.

The CAR-T cell therapy Aucatzyl was approved for relapsed or refractory B-cell precursor acute lymphoblastic leukemia based on findings from the FELIX trial.

CURE partnered with UCLA Health and Northside Hospital Cancer Institute for an on-demand webinar series on managing side effects of breast cancer treatment.

In this on-demand webinar series, CURE partnered with UCLA Health and Northside Hospital Cancer Institute to discuss best approaches to tracking side effects for patients with breast cancer.

An expert explained how a patient’s own T cells can be extracted, manufactured and infused back into the body as a treatment option for melanoma.

The actor, 65, received his diagnosis of stage 3 non-Hodgkin lymphoma in October, he said.

Lymphedema risk varies significantly by cancer type and lymph node removal extent, necessitating personalized risk assessments.

The FDA approved a phase 3 trial for amezalpat with Tecentriq and Avastin in hepatocellular carcinoma treatment.